Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells. - Cioca,D.P.; Deak,E.; Cioca,F.; Paunescu,V. (J Immunother, 2006)